Total planned funding: $256,171,054
Allocations
Countries/Regions
Eswatini | $256,171,054 |
Organizational Types
Unknown | $58,796,662 |
Private Contractor | $53,335,976 |
NGO | $49,463,104 |
University | $45,601,572 |
Own Agency | $29,435,450 |
Host Country Government Agency | $7,383,459 |
FBO | $6,188,454 |
Multi-lateral Agency | $3,366,724 |
Other USG Agency | $1,790,053 |
Implementing Agency | $809,600 |
Program Areas
Care | $76,513,744 |
Prevention | $53,076,674 |
Treatment | $49,373,803 |
Governance and Systems | $36,917,280 |
Testing | $22,213,549 |
Management and Operations | $18,076,004 |
Budget Codes
HTXS: Treatment: Adult Treatment | $39,859,224 |
HBHC: Care: Adult Care and Support | $33,367,960 |
HKID: Care: Orphans and Vulnerable Children | $22,280,169 |
HVCT: Testing: HIV Testing and Counseling | $22,213,549 |
HVSI: Strategic Information | $20,594,014 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $19,497,324 |
HVMS: Management and Operations | $18,076,004 |
HVTB: Care: TB/HIV | $14,285,375 |
OHSS: Health Systems Strengthening | $12,084,945 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $11,869,104 |
HVOP: Sexual Prevention: Other Sexual Prevention | $11,100,854 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $9,012,392 |
PDCS: Care: Pediatric Care and Support | $6,580,240 |
HTXD: Treatment: ARV Drugs | $5,312,964 |
HLAB: Laboratory Infrastructure | $4,238,321 |
PDTX: Treatment: Pediatric Treatment | $4,201,615 |
HMBL: Biomedical Prevention: Blood Safety | $1,597,000 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Not Available:
$54,397,676
Countries/Regions
Columbia University:
$36,609,037
Countries/Regions
Pact, Inc.:
$27,415,961
Countries/Regions
USG Aggregated Agencies:
$17,506,102
Countries/Regions